Home  >  Products  >  CASP7 (caspase 7, apoptosis-related cysteine peptidase) Blocking Peptide (the N terminal of CASP7)(100ug)
CASP7 (caspase 7, apoptosis-related cysteine peptidase) Blocking Peptide (the N terminal of CASP7)(100ug)

CASP7 (caspase 7, apoptosis-related cysteine peptidase) Blocking Peptide (the N terminal of CASP7)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CASP7 Antibody (ARP58995_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP58995
Size: 100ug
Weight: 37kDa
Gene: 840
Format: Lyophilized powder
Target: This gene encodes a protein which is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. The precursor of this caspase is cleaved by caspase 3 and 10. It is activated upon cell death stimuli and induces apoptosis. Alternative splicing results in four transcript variants, encoding three distinct isoforms.
Alternative names: CMH-1; ICE-LAP3; MCH3
See Full Product Listings >